Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.23 | N/A |
| PEG Ratio (TTM) | -0.19 | N/A |
| P/S Ratio (TTM) | 2.04 | N/A |
| P/B Ratio (TTM) | 0.93 | N/A |
| P/FCF Ratio (TTM) | 3.47 | N/A |
| Price to 5YR AVG Earnings Ratio | 6.77 | N/A |
| Price to 5YR AVG FCF Ratio | 6.68 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 12.89% | N/A |
| ROE (TTM) | 22.77% | N/A |
| Net Profit Margin (TTM) | 47.87% | N/A |
| ROIC 5YR AVG | 11.90% | N/A |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -27.27% | 103.11% | 105.43% |
| Revenue | -11.91% | 30.85% | 35.71% |
| Net Income | -26.74% | 93.34% | 99.60% |
| Cash Flow | 13.52% | 601.25% | 400.05% |
Health (89%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 4.22 | N/A |
| Quick Ratio (TTM) | 4.20 | N/A |
| D/E Ratio (TTM) | 0.53 | N/A |
| Interest Coverage (TTM) | 7.37 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 2.04 | N/A |
| LTL to 5YR AVG FCF | 4.64 | N/A |
| Shares Outstanding Growth 5YR AVG | -5.57% | N/A |